TB-500
A 43-amino-acid peptide that promotes systemic healing through actin regulation and endothelial cell mobilization.
Also known as: Thymosin Beta-4, Thymosin β-4, RGN-259
Available on Forge Amino
TB-500 10MG — independently lab tested, 99%+ purity, QR-linked COA.
Important: This content is for informational and research purposes only and is not intended for human or veterinary use. Consult your physician for health-related guidance and laboratory monitoring.
How It Works
Binds and sequesters G-actin, regulating cytoskeletal dynamics and cell migration. Activates PI3K/Akt/eNOS pathways to promote endothelial progenitor cell mobilization and angiogenesis.
Key Benefits
- ✓Accelerated wound closure and tissue healing
- ✓Enhanced cell migration and fibroblast activity
- ✓Systemic anti-inflammatory response
- ✓Improved endothelial function
- ✓Cell survival under oxidative stress
Dosing Protocols
Beginner / Intermediate
Dose
1-2.5 mg
Frequency
2-3x weekly subcutaneous
Cycle Length
4-6 weeks
Notes
1 mg every other day for the first 4 weeks as a loading phase
Advanced
Dose
5 mg
Frequency
2-3x weekly subcutaneous
Cycle Length
6-8 weeks
Notes
Supports systemic regeneration across multiple tissues
Side Effects & Safety
Common Side Effects
- Injection site reactions
- Transient fatigue during loading phase
- Mild headache
- Rare: fever or muscle aches
Contraindications
- Active malignancy (pro-angiogenic)
- History of cancer (relative caution)
- Pregnancy and lactation
- Uncontrolled hypertension
Stacking & Synergies
These compounds have complementary mechanisms and may enhance results when used together.
Key Takeaway
Multiply your recovery: TB-500 amplifies cellular healing through systemic cell mobilization and angiogenesis.
Research Disclaimer: This content is for informational and research purposes only. It is not medical advice. These products are not approved by the FDA for human consumption. Consult a qualified healthcare provider before starting any new protocol. The information provided is based on preclinical research and anecdotal reports and has not been formally evaluated in randomized controlled trials.